Impact of ivabradine in decompensated heart failure due to cancer therapy ‐related cardiac dysfunction

In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorable hemodynamics. Assessment of the overlap between the E- and A-waves facilitates understanding the effects of ivabradine in such cases. Key Clinical MessageIn cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorable hemodynamics. Assessment of the overlap between the E- and A-waves facilitates understanding the effects of ivabradine in such cases.

Source: Clinical Case Reports - May 5, 2021 Category: General Medicine Authors: Yusuke Nakano, Hirohiko Ando, Wataru Suzuki, Hirofumi Ohashi, Yasushi Suzuki, Hiroaki Takashima, Tetsuya Amano Tags: CASE REPORT Source Type: research